Early research (Phase 1)Ended earlyNCT02326935
What this trial is testing
Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis
Who this might be right for
Multiple Sclerosis
American CryoStem Corporation 2